Part of Germany’s Science Year 2026, the project looks forward ten years to explore how AI—symbolized by the assistant robot Garmi—can enhance medical care. It focuses on the “patient journey,” covering everything from childhood genetic analysis to geriatric assistance systems.
Key Features of the Project
- Interactive Digital Platform: Users can navigate five life-stage scenarios (such as robotic surgery or wearables) to compare AI-assisted treatments with today’s standard therapies.
- Public Collaboration: Unlike traditional research projects, the content is being co-created with the public. Dialogue workshops held in April 2026 allowed citizens to prioritize which topics and concerns the project should address.
- Strategic Partnerships: The project is a joint effort by the Munich Medicine Alliance (M1)—which includes TUM, LMU, and Helmholtz Munich—alongside the publisher Wort & Bild Verlag to ensure the information is accessible to non-scientists.
Goals & Outreach
- Target Audience: Primarily adults aged 40 and older who are interested in the evolution of healthcare.
- Objective: To build public trust by transparently showcasing both the potential benefits and the limitations of AI in medicine.
- Engagement: Information will be shared via major health platforms (like apotheken-umschau.de) and through five public expert events held across the greater Munich area.
